NYU LANGONE HEALTH / NYU GROSSMAN SCHOOL OF MEDICINE Researchers at NYU Grossman School of Medicine and Janssen Biotech, Inc. have shown in early tests that a bioengineered drug candidate can counter infection with Staphylococcus aureus – a bacterial species widely resistant to antibiotics and a major cause of death in hospitalized patients. Experiments demonstrated that SM1B74, an...
Tag: <span>early tests</span>
Post
Omicron-targeted vaccines do no better than original jabs in early tests
Emily Waltz Ambulances queue at a London hospital during a COVID-19 surge driven by the Omicron variant. Credit: Mark Thomas/Shutterstock As the Omicron variant of SARS-CoV-2 continues its global rampage, vaccine makers are pouring resources into clinical trials of COVID-19 shots tailored to the highly transmissible variant. But a raft of early animal studies suggest...